Skin cancer mortality statistics

Deaths

Deaths from malignant melanoma, 2014, UK

 

Proportion of all deaths

Percentage malignant melanoma is of total cancer deaths, 2014, UK

 

Age

Peak rate of malignant melanoma deaths, 2012-2014, UK

 

Malignant melanoma is the 17th most common cause of cancer death in the UK (2014), accounting for 2% of all cancer deaths.[1-3] In males, it is the 16th most common cause of cancer death in the UK (2% of all male cancer deaths), whilst it is the 16th most common cause of cancer death in females in the UK (1% of all female cancer deaths).[1-3]

In 2014, there were 2,459 malignant melanoma deaths in the UK: 1,431 (58%) in males and 1,028 (42%) in females, giving a male:female ratio of around 14:10.[1-3] The crude mortality rate Open a glossary item shows that there are 5 malignant melanoma deaths for every 100,000 males in the UK, and 3 for every 100,000 females.

The European age-standardised mortality rates Open a glossary item (AS rates) do not differ significantly between the constituent countries of the UK for either sex.[1-3]

Malignant Melanoma (C43), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2014

England Wales Scotland Northern Ireland UK
Male Deaths 1,224 78 100 29 1,431
Crude Rate 4.6 5.1 3.9 3.2 4.5
AS Rate 5.5 5.8 4.6 4.9 5.4
AS Rate - 95% LCL 5.2 4.5 3.7 3.1 5.1
AS Rate - 95% UCL 5.8 7.0 5.5 6.6 5.7
Female Deaths 856 71 76 25 1,028
Crude Rate 3.1 4.5 2.8 2.7 3.1
AS Rate 3.1 4.2 2.7 2.9 3.1
AS Rate - 95% LCL 2.9 3.2 2.1 1.7 2.9
AS Rate - 95% UCL 3.3 5.2 3.3 4.0 3.3
Persons Deaths 2,080 149 176 54 2,459
Crude Rate 3.8 4.8 3.3 2.9 3.8
AS Rate 4.2 4.9 3.5 3.6 4.1
AS Rate - 95% LCL 4.0 4.1 3.0 2.6 4.0
AS Rate - 95% UCL 4.4 5.6 4.0 4.5 4.3

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS rate Open a glossary item

Malignant melanoma mortality rates throughout the UK show very little variation between health boundaries for both males and females.[5,6]

References

  1. Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/previousReleases
  2. Data were provided by Information Services Division (ISD) Scotland on request, November 2015. Similar data can be found here: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/vital-events-reference-tables
  3. Data were provided by the Northern Ireland Statistics and Research Agency on request, November 2015. Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp2.htm.
  4. National Cancer Intelligence Unit. Mortality, Incidence and Gender Malignant melanoma. 2012.
  5. NCIN. Cancer Incidence and Mortality by Cancer Network, UK, 2005. London: NCIN; 2008.
  6. NCIN. Cancer e-Atlas. European Age-Standardised Mortality Rates, UK (England: former Primary Care Trusts; Wales; Scotland: NHS Health Boards; Northern Ireland: Health and Social Care Trusts), 2009-2011.
Last reviewed:

Malignant melanoma mortality is strongly related to age, with the highest mortality rates being in older males and females. In the UK in 2012-2014, on average each year more than half (54%) of deaths were in people aged 70 and over.[1-3]

Age-specific mortality rates rise sharply from around age 50-54 years in males and 55-59 years in females, with the highest rates in the 90+ age group. Mortality rates are significantly higher for males than for females in those aged 55-59 and over and this gap is widest at the ages of 75-79, when the male:female ratio of age-specific  rates (to account for the different proportions of males to females in each age group) is around 20:10.[1-3]

Malignant Melanoma (C43), Average Number of Deaths per Year and Age-Specific Mortality Rates, UK, 2012-2014

For most cancer types, mortality by age largely reflects incidence and survival by age, e.g. typically, higher incidence and lower survival in older people results in higher mortality in older people.

References

  1.  Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/previousReleases.
  2. Data were provided by the Information Services Division (ISD) Scotland on request, November 2015. Similar data can be found here: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/vital-events-reference-tables.
  3. Data were provided by the Northern Ireland Statistics and Research Agency on request, November 2015.Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp2.htm.
Last reviewed:

Malignant melanoma mortality rates have increased overall in the UK since the early 1970s.[1-3] For males, European AS mortality rates Open a glossary item increased by 184% between 1971-1973 and 2010-2012. The rise is smaller for females, with rates increasing by 51% between 1971-1973 and 2010-2012. From the late 1980s onwards, mortality rates have increased much more quickly in males than in females, causing a divergence of the rates between the sexes. This is in contrast to malignant melanoma incidence rates in males and females, which have converged in the last decades.

Over the last decade (between 2000-2002 and 2010-2012), European AS mortality rates have increased by 20% in males and remained stable in females. The increase in malignant melanoma mortality rates is likely to be a reflection of the increase in incidence rates. The increase in mortality rates is much less pronounced, however, due to improvements in survival (as a result of earlier diagnosis and better treatment). The lower mortality rates in females compared to males since the mid-1980s mirror the better survival rates seen in women.

Malignant Melanoma (C43), European Age-Standardised Mortality Rates, UK, 1971-2012

Malignant melanoma mortality rates have increased overall for most of the broad adult age groups in the UK since the early 1970s, except those aged 15-39 and 40-49 years.[1-3] The largest increases have been in people aged 75 years and over, mirroring the large increase in incidence in this age group over time, with European AS mortality more than quadrupling between 1971-1973 and 2010-2012. The increase in mortality rates in the older age groups may also be explained in part by late presentation of patients with more advanced tumours.[4]

Malignant Melanoma (C43), European Age-Standardised Mortality Rates, By Age, Persons, UK, 1971-2012

References

  1. Data were provided by the Office for National Statistics on request, January 2014. Similar data can be found here: http://www.ons.gov.uk/ons/publications/all-releases.html?definition=tcm%3A77-27475
  2. Data were provided by ISD Scotland on request, March 2014. Similar data can be found here: http://gro-scotland.gov.uk/statistics/theme/vital-events/general/ref-tables/index.html
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2013. Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp22.htm.
  4. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed December 2013.
Last reviewed:

Malignant melanoma is the 19th most common cause of cancer death in Europe, with around 22,200 deaths from malignant melanoma in 2012 (1% of the total). In Europe (2012), the highest World age-standardised Open a glossary item mortality rates for malignant melanoma are in Norway for men and Slovenia for women; the lowest rates are in Albania for men and Malta for women. UK malignant melanoma mortality rates are estimated to be the 19th highest in males in Europe, and 17th highest in females.[1] These data are broadly in line with Europe-specific data available elsewhere.[2]

There were around 55,500 deaths from malignant melanoma worldwide in 2012 (0.7% of total cancer deaths). Malignant melanoma mortality rates are highest in Australia/New Zealand and lowest in South Central Asia, but this partly reflects varying data quality worldwide.[1]

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed December 2013. 
  2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al.Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer (2013) 49, 1374-1403.
Last reviewed:

Non-melanoma skin cancer (NMSC) accounts for less than 1% of all cancer deaths in the UK (2014), for both males and females.[1-3]

In 2014, there were 781 NMSC deaths in the UK: 492 (63%) in males and 289 (37%) in females, giving a male:female ratio of around 17:10.[1-3] The crude mortality rate Open a glossary item shows that there are 2 NMSC deaths for every 100,000 males in the UK, and less than 1 for every 100,000 females.

The European age-standardised mortality rate Open a glossary item (AS rate) is significantly higher in Scotland compared with England for males only.[1-3] There are no significant differences between the other constituent countries of the UK for either sex.

Non-melanoma Skin Cancer (C44), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2014

England Wales Scotland Northern Ireland UK
Male Deaths 387 22 65 18 492
Crude Rate 1.4 1.4 2.5 2.0 1.5
AS Rate 2.0 1.9 3.3 3.6 2.1
AS Rate - 95% LCL 1.8 1.1 2.5 1.9 1.9
AS Rate - 95% UCL 2.2 2.7 4.2 5.2 2.3
Female Deaths 239 15 29 6 289
Crude Rate 0.9 1.0 1.1 0.6 0.9
AS Rate 0.8 0.8 1.0 0.7 0.8
AS Rate - 95% LCL 0.7 0.4 0.7 0.1 0.7
AS Rate - 95% UCL 0.9 1.2 1.4 1.2 0.9
Persons Deaths 626 37 94 24 781
Crude Rate 1.2 1.2 1.8 1.3 1.2
AS Rate 1.3 1.2 2.0 1.7 1.3
AS Rate - 95% LCL 1.2 0.8 1.6 1.0 1.2
AS Rate - 95% UCL 1.4 1.6 2.4 2.4 1.4

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS rate

References

  1. Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/previousReleases.
  2. Data were provided byInformation Services Division (ISD) Scotland on request, November 2015. Similar data can be found here: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/vital-events-reference-tables.
  3. Data were provided by the Northern Ireland Statistics and Research Agency on request, November 2015. Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp2.htm.
Last reviewed:

There is evidence for an association between skin cancer mortality and deprivation in both males and females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 37% lower for males living in the most deprived areas compared with the least deprived, and 35% lower for females.[1] Malignant melanoma is one of the few cancers where mortality rates are lower for more deprived males and females compared to less deprived males and females.

Malignant Melanoma (C43), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in skin cancer mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1] It is estimated that there would have been around 270 more deaths each year in England during 2007-2011 if all people experienced the same mortality rates as the least deprived.[1]

Last reviewed:

Cancer Statistics Explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year]. 

Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK. 

Rate this page:

Currently rated: 2.6 out of 5 based on 5 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page